Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostaglandin E receptors.

Yukihiko Sugimoto1, Shuh Narumiya

  • 1Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, Faculty of Medicine, Kyoto University, Kyoto 606-8501, Japan.

The Journal of Biological Chemistry
|March 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Sphingosine-1-phosphate receptor 1/5 selective agonist alleviates ocular vascular pathologies.

Scientific reports·2026
Same author

Stress-induced CXCL13 regulates pancreatic exocrine homeostasis, age-related chronic inflammation, and cancer progression.

Science advances·2026
Same author

Publisher Correction: F- and G-actin homeostasis regulates mechanosensitive actin nucleation by formins.

Nature cell biology·2026
Same author

The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.

British journal of pharmacology·2025
Same author

Tumor-initiating stem cells fine-tune the plasticity of neutrophils to sculpt a protective niche.

Cancer cell·2025
Same author

Prostaglandin E<sub>2</sub>-EP2/EP4 signaling induces the tumor-infiltrating Treg phenotype for tumor growth.

Proceedings of the National Academy of Sciences of the United States of America·2025

Prostaglandin E2 (PGE2) signals through four G-protein-coupled receptors (EP1-EP4). Research highlights the diverse roles of these EP receptor subtypes in various physiological and pathophysiological processes.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Prostaglandin E2 (PGE2) is a key signaling molecule that mediates its effects through G-protein-coupled receptors (GPCRs).
  • Four distinct EP receptor subtypes (EP1, EP2, EP3, and EP4) have been identified, with EP3 further exhibiting multiple splicing isoforms.
  • These EP receptor subtypes display heterogeneity in signal transduction, tissue distribution, and gene expression regulation, contributing to PGE2's versatile biological functions.

Purpose of the Study:

  • To review recent advancements in the understanding of Prostaglandin E2 (PGE2) receptor research.
  • To elucidate the distinct roles and mechanisms of action of the EP receptor subtypes (EP1, EP2, EP3, EP4).

Main Methods:

  • Review of recent scientific literature on Prostaglandin E2 (PGE2) receptor research.

Related Experiment Videos

  • Analysis of studies utilizing knock-out mouse models deficient in specific EP receptor subtypes.

    • Main Results:

    • Studies on EP receptor knock-out mice have delineated the specific physiological and pathophysiological functions mediated by each PGE2 receptor subtype.
    • The molecular and biochemical heterogeneity of EP receptors underscores the diverse actions of PGE2.

    Conclusions:

    • The distinct characteristics of EP receptor subtypes (EP1-EP4) are crucial for mediating the wide-ranging effects of Prostaglandin E2 (PGE2).
    • Continued research into PGE receptor subtypes is essential for understanding various physiological and pathophysiological responses.